Lindbrook Capital’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$6.63K Sell
70
-13
-16% -$1.38K ﹤0.01% 1838
2024
Q4
$9.13K Hold
83
﹤0.01% 1698
2024
Q3
$9.39K Sell
83
-19
-19% -$2.21K ﹤0.01% 1710
2024
Q2
$12.6K Hold
102
﹤0.01% 1501
2024
Q1
$13.2K Hold
102
﹤0.01% 1412
2023
Q4
$12.6K Sell
102
-14
-12% -$1.49K ﹤0.01% 1418
2023
Q3
$11.9K Buy
116
+31
+36% +$3.24K ﹤0.01% 1324
2023
Q2
$8.54K Sell
85
-48
-36% -$4.81K ﹤0.01% 1562
2023
Q1
$13.7K Hold
133
﹤0.01% 1262
2022
Q4
$13.7K Buy
133
+52
+64% +$5.28K ﹤0.01% 1274
2022
Q3
$7K Buy
81
+35
+76% +$3.31K ﹤0.01% 1494
2022
Q2
$4K Buy
+46
New +$4.47K ﹤0.01% 1652

Other funds holding IOSP

Lindbrook Capital's IOSP Position: Q1 2025 in Review

Lindbrook Capital reduced its Innospec (IOSP) stake by 16% in Q1 2025, selling an estimated $1.38K and leaving 70 shares worth $6.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

Lindbrook Capital first reported a position in IOSP in Q2 2022 and has held it in 12 quarters since. The position peaked at $13.7K in Q4 2022. 272 funds tracked by Wall St. Rank hold IOSP as of Q1 2025.

  • Lindbrook Capital held 70 shares of Innospec worth $6.63K as of Q1 2025.
  • Lindbrook Capital sold 13 Innospec shares in Q1 2025, an estimated $1.38K.
  • Innospec made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1838 holding.
  • Lindbrook Capital first reported a position in Innospec in Q2 2022 and has held it in 12 quarters since.
  • Lindbrook Capital's Innospec position peaked at $13.7K in Q4 2022.
  • 272 funds tracked by Wall St. Rank held Innospec as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.